GBM is characterized by wild-type IDH genes with the so-called GBM genotypes, such as TERT promoter mutation, EGFR gene amplification, and gain of chromosome 7 plus loss of chromosome 10 (7+/10−). This evidence concerns the gene EGFR and glioblastoma.